A Newcastle-based life sciences company has raised £1.5 million worth of investment to help develop a ground-breaking treatment that could provide a treatment for patients suffering from early stage oral cancer. LightOx has raised money to develop its lead candidate LXD191, an oral gel that is activated by a light device that targets a serious … Continue reading Oral cancer prevention firm LightOx plots Manchester expansion